公司资料
Virax Biolabs 股价、新闻与催化剂
- 股票代码:
- VRAX
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United Kingdom and listed in the U
股票表现
2.81 USD (-1.75%)
收盘价
最后更新: 2026年8月17日
1.61M USD
市值
股价为何变动
As of Aug 17, 2026, VRAX closed down 1.75% at $2.81. No new same-company headline was identified in the current news window.
公司概览
业务概览
Virax Biolabs is a diagnostics company focused on immune profiling and infectious-disease testing. Its business is centered on molecular and laboratory diagnostics rather than therapeutics.
所在地与行业分类
Virax Biolabs is headquartered in the United Kingdom and listed in the U.S. market. It sits in diagnostics and medical devices rather than biotechnology.
商业模式特征
The company depends on product adoption, test utilization, and commercialization in a competitive diagnostics market. Investors watch market access, product rollout, and operating execution.
生物医药行业定位
Virax occupies the diagnostics layer of the healthcare stack. It is not a biotech drug name, but it belongs to the broader testing infrastructure that supports care decisions.
未来催化剂
- Virax’s catalysts are infectious-disease and immune-profiling programs, plus any update that shows the platform can still create value. The next step matters because the company remains early.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。